Stem cell research in China-Reference-Cited by-同舟云学术

Stem cell research in China

Published:2007-03-05 Issue:1482 Volume:362 Page:1107-1112
ISSN:0962-8436
Container-title:Philosophical Transactions of the Royal Society B: Biological Sciences
language:en
Short-container-title:Phil. Trans. R. Soc. B

Author:

Liao Lianming¹,Li Lingsong²,Zhao Robert Chunhua¹

Affiliation:

1. Centre of Excellence in Tissue Engineering, Institute of Basic Medical Sciences and School of Basic Medicine, Chinese Academy of Medical Sciences and Peking Union Medical CollegeDongdan Santiao No. 5, Beijing 100005, People's Republic of China

2. Peking University Stem Cell Research CentreBeijing 100083, People's Republic of China

Abstract

In the past 5 years, China has increased its efforts in the field of stem cell research and practice. Basic research mainly focuses on bone marrow and embryonic stem cells. Clinical applications of stem cells in the treatment of acute heart failure, acute liver failure and lower limb ischaemia have been reported by many hospitals. China enacted its ‘Ethical Guidelines for Human Embryonic Stem Cell Research’ in 2003. At present, China has the most liberal and favourable environments for human embryonic stem cell research.

Publisher

The Royal Society

Subject

General Agricultural and Biological Sciences,General Biochemistry, Genetics and Molecular Biology

Link

https://royalsocietypublishing.org/doi/pdf/10.1098/rstb.2007.2037

Reference30 articles.

1. Human adipose tissue-derived stem cells differentiate into endothelial cells in vitro and improve postnatal neovascularization in vivo

2. Embryonic stem cells generated by nuclear transfer of human somatic nuclei into rabbit oocytes

3. Repair of infarcted myocardium by intramyocardial transplantation of mobilized autologous bone nlaiTow stem cells in humans;Chen Y.X;Chin. J. Pathophysiol,2003

4. Effect on left ventricular function of intracoronary transplantation of autologous bone marrow mesenchymal stem cell in patients with acute myocardial infarction

5. Allogeneic bone marrow–derived flk-1+Sca-1− mesenchymal stem cells leads to stable mixed chimerism and donor-specific tolerance

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Past Trends in Decisions and Conditioning Factors;Embryonic Stem Cells and the Law;2024

2. Introduction;Embryonic Stem Cells and the Law;2024

3. Are we ready for the revision of the 14-day rule? Implications from Chinese legislations guiding human embryo and embryoid research;Frontiers in Cell and Developmental Biology;2022-10-24

4. Systematic evaluation of therapeutic effects of stem cell transplantation trials for heart diseases in China;Clinical Transplantation;2020-10-19

5. Global trends in clinical trials involving pluripotent stem cells: a systematic multi-database analysis;npj Regenerative Medicine;2020-09-11